Sudha Seshadri, MD
Location: Robinson, B602
Dr. Sudha Seshadri completed her MBBS from the Christian Medical College, Madras University, and her MD in Internal Medicine and DM in Neurology from the All India Institute of Medical Sciences, New Delhi, India. Additionally, she has completed a Residency in Neurology at the Boston University School of Medicine and a Fellowship in the Neurobiology of Aging and Alzheimer Disease at the University of Massachusetts Medical Center. She has previously worked as Assistant Professor of Neurology at the All India Institute of Medical Sciences, New Delhi, and joined the Boston University School of Medicine’s Department of Neurology in May 2001 as Assistant Professor in the Department of Neurology. She also serves as Co-Director of Medical Education for the Neurology Residency and Clerkship programs.
Dr. Seshadri is an Investigator in the Framingham Heart Study and her research interests include Alzheimer’s disease, age-related cognitive decline, stroke and vascular dementia.
Dr. Seshadri works to facilitate joint research between the ADC and the Framingham Heart Study. She also sees patients with memory loss and Alzheimer’s disease in her clinic at the Boston University Neurological Associates on Friday afternoons.
Awards: E. Merck Gold Medal in Neurology and Allied Sciences.
Member: Alpha Omega Alpha, American Academy of Neurology, American Medical Association, Massachusetts Medical Society, World Federation of Neurology, Alzheimer’s and Related Disorders Society of India, Neurological Society of India, Indian Academy of Neurology, Scientific Council of American Stroke Association.
Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356:1627-31. [PDF]
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346: 476-83. [PDF]
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime Risk of Stroke and Dementia: Estimates from the Framingham Study. Stroke 2006;37(2): 345-350. [PDF]
Akomolafe A, Beiser AS, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S. Diabetes mellitus and risk of developing Alzheimer’s dementia: results from the Framingham Study. Arch Neurol. 2006; 63:1551-5. [PDF]
Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S. Relation of Obesity to Cognitive Function: Importance of Central Obesity and Synergistic Influence of Concomitant Hypertension. The Framingham Heart Study. Cur Alzheimer Res 2007;4;2: 111-116. [PubMed]
Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S. Inflammatory markers and the risk of Alzheimer’s disease: The Framingham Study. Neurology 2007; 68 1902-1908. [PDF]
Seshadri S, DeStefano AL, Au R, Massaro JM, Beiser AS, Kelly-Hayes M, Kase CS, D’Agostino RB, DeCarli C, Atwood LD, Wolf PA. Genetic correlates of brain aging on MRI and cognitive test measures: a genome wide association and linkage analysis in the Framingham study. BMC Med Genet 2007, 8 (Suppl 1): S15. [PDF]